Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Clinical Trial
. 1989 Oct;33(10):1709-13.
doi: 10.1128/AAC.33.10.1709.

Effects on oral and intestinal microfloras of norfloxacin and pefloxacin for selective decontamination in bone marrow transplant patients

Affiliations
Clinical Trial

Effects on oral and intestinal microfloras of norfloxacin and pefloxacin for selective decontamination in bone marrow transplant patients

M Giuliano et al. Antimicrob Agents Chemother. 1989 Oct.

Abstract

We monitored the modifications of oral and intestinal microfloras of 10 allogeneic bone marrow recipients who received randomly either norfloxacin or pefloxacin (400 mg three times a day) as selective decontamination for infection prevention. After 1 week of treatment, in all patients members of the family Enterobacteriaceae were no longer detectable and in all but one pefloxacin-treated patient enterococci were also eliminated in the intestine. The anaerobic flora was not affected, with the exception of Bacteroides spp., markedly reduced after treatment with pefloxacin. In most patients the most striking effect was the increase in staphylococcal counts. These strains were found to be resistant to both quinolones in the study. Less consistent changes were observed in oral flora. No relevant difference could be demonstrated between the two regimens on bacterial counts either in feces or in saliva. This study shows the efficacy of both quinolones in eradicating gram-negative bacilli in the alimentary tract of bone marrow transplant patients; however, the finding of the overgrowth of resistant gram-positive organisms during treatment with these agents deserves further evaluation.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ann Intern Med. 1980 Aug;93(2):358-61 - PubMed
    1. Antimicrob Agents Chemother. 1989 Feb;33(2):209-11 - PubMed
    1. Antimicrob Agents Chemother. 1981 Nov;20(5):620-4 - PubMed
    1. Ann Intern Med. 1982 Oct;97(4):503-8 - PubMed
    1. Arch Intern Med. 1983 Jan;143(1):32-6 - PubMed

Publication types